Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.
about
Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritisMechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Osteoporosis in the rheumatic disease patient.TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.Oral salmon calcitonin--pharmacology in osteoporosis.
P2860
Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@ast
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@en
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@nl
type
label
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@ast
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@en
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@nl
prefLabel
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@ast
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@en
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Intranasal calcitonin for the ...... loss in rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1136/ARD.51.6.761
P407
P577
1992-06-01T00:00:00Z